Psychedelic assisted therapy is rebuilding on narrower, more rigorous trial designs
Dr. Dereck Mush, MD, MBA
Mindbloom
Clinical platform offering guided, at-home ketamine therapy for anxiety and depression.
What they do
Mindbloom is a telemedicine platform delivering guided ketamine therapy for depression and anxiety. Customers receive home-delivered treatments, clinical management from psychiatric clinicians, and preparation and integration coaching from trained guides via video.
The record
- Vertical
- Mental & Behavioural Health
- Sub-segment
- Psychedelic-assisted therapy
- Product type
- Service
- Stage
- Series A
- Headquarters
- Austin, USA
- Region
- North America
- Founded
- 2018
- Total funding
- $36M raised
Notable investors: Founders Fund, 8VC, Defining Ventures.
Also in Mental & Behavioural Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
Dr. Dereck Mush, MD, MBA
AI note taking tools are spreading through behavioral health faster than AI treatment tools
Dr. Dereck Mush, MD, MBA
Measurement based care is becoming behavioral health's real quality metric
Dr. Dereck Mush, MD, MBA